Millions of osteoporosis patients worldwide are set to benefit from a major international breakthrough, which will transform ...

But new research suggests that a simple blood test may be able to predict osteoporosis risk, allowing doctors to intervene ...

Boston-based Beth Israel Deaconess Medical Center played a role in a new FDA decision that allows bone mineral density, measured through noninvasive imaging, to serve as a qualified endpoint in ...

Although there are several effective anti-osteoporosis drugs on the market today, new therapies with improved safety profiles and efficacy are still needed. The FDA called osteoporosis-related ...

Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides and proteins replacement therapies, today announced new validating in vivo pharmacokinetic and ...

SEOUL, Dec. 22 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutical company, said Monday it has launched its biosimilar drug Stoboclo-Osenvelt in major European markets, following the ...

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

There is 'no evidence' that the drugs frequently used by menopausal women impact the risk of the disease, a review has found.

The analysis, published in The Lancet Healthy Longevity, concluded there was "no significant association" between HRT and the ...

Clinical excellence, the incorporation of cutting-edge technology, and a care model focused on rapid patient recovery have ...

Introduction of AVT05 supported by NHS England tender award in the United KingdomREYKJAVIK, Iceland, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech ...